Skip to content
10-K

Annual Report

Lucid Diagnostics Inc. LUCD

0001437749-26-009805

← back to feed
Filed
Mar 25, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 23, 2026 176.95M sh
Capex FY 2025 · Dec 31, 2025 $197K
Capex FY 2025 · Dec 31, 2024 $296K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$46.49M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$44.14M
Stockholders Equity FY 2025 · Dec 31, 2025 $10.94M
Stockholders Equity FY 2025 · Dec 31, 2024 $5.39M
Stockholders Equity FY 2025 · Dec 31, 2023 −$2.31M
Current Liabilities FY 2025 · Dec 31, 2025 $28.58M
Current Liabilities FY 2025 · Dec 31, 2024 $23.52M
Total Liabilities FY 2025 · Dec 31, 2025 $29.51M
Total Liabilities FY 2025 · Dec 31, 2024 $25.32M
Current Assets FY 2025 · Dec 31, 2025 $37.47M
Current Assets FY 2025 · Dec 31, 2024 $25.15M
Total Assets FY 2025 · Dec 31, 2025 $40.45M
Total Assets FY 2025 · Dec 31, 2024 $30.72M
Eps Basic FY 2025 · Dec 31, 2025 −$0.69
Eps Basic FY 2025 · Dec 31, 2024 −$1.05
Rd Expense FY 2025 · Dec 31, 2025 $5.68M
Rd Expense FY 2025 · Dec 31, 2024 $5.99M
Net Income FY 2025 · Dec 31, 2025 −$58.01M
Net Income FY 2025 · Dec 31, 2024 −$45.53M
Operating Income FY 2025 · Dec 31, 2025 −$49.64M
Operating Income FY 2025 · Dec 31, 2024 −$46.05M
Cost Of Revenue FY 2025 · Dec 31, 2025 $6.67M
Cost Of Revenue FY 2025 · Dec 31, 2024 $7.1M